PPT-Immuno-Oncology Applications

Lee S Schwartzberg MD FACP West Clinic PC The University of Tennessee Memphis Tn ICLIO 1 st Annual National Conference 10215 Philadelphia Pa Financial Disclosures I do not currently have any relevant financial relationships to disclose. The In-Practice Pharmacy Value Proposition & Need for a National Association. Ricky Newton, CPA. Orlando, Florida. April 24, 2015. Do you have one of the following within your practice currently?. WEBSITE www.immuno way .com MAILorder@immunoway.com immuno way .com CD298 Polyclonal AntibodyCatalog No.:YT5623 For esearch se nly WEBSITE www.immuno way .com MAILorder@immunoway.com tech@ immuno wa Gary E. Foresman, MD. February 2012. “In 2010, about 600,000 Americans, and more than 7 million humans around the world, will die of cancer. . In the United States, 1 in 3 women and 1 in 2 men will develop cancer during their lifetime. . ASCO June 2014. Susan Dent. Medical Oncologist. The Ottawa Hospital Cancer Center. Ottawa, Canada. The problem . Cancer Survivors (Million) 2012 - 2018. Brigham, MGH. MSK. U Penn. Medstar. Washington. The In-Practice Pharmacy Value Proposition & Need for a National Association. Ricky Newton, CPA. Orlando, Florida. April 24, 2015. Do you have one of the following within your practice currently?. The Need for Measurement. Payers (Medicare and private insurers) are demanding quality, cost control, accountability, and predictability. Measuring . quality and value in cancer care now enabled by IT . Pharma-Biotech BD&L Panel. Co-Chairs: . Mike Rice. , Senior Consultant, Defined Health. Peter Hoang, . Senior Vice President, Business Development & Strategy, Bellicum Pharmaceuticals . Panelists:. Medical Oncology Updates Presentation by Mary Hill Library Manager The Christie NHS Foundation Trust Putting it into context Cancer specialist hospital with strong research focus A lot of research fellows & one suggested they wanted Maximizing Nutrition in Oncology Patients Laura Kerns, MPH, RD, CSO, LDN Board Certified Specialist in Oncology Nutrition Malnutrition and cachexia Malabsorption XRT and feeding tubes Opioid induced constipation Sophia . Lamey.  . Background .  . Many advances have been made in recent years in profiling cancers on a more specific cellular or genetic level. These new technologies have led to insights for cancer treatment decisions. . FRONTIER The science behind the Nobel Prizes in Medicine and Chemistry is the core in Alligator’s research and development 2 FRONTIERA MAGAZINE ABOUT ALLIGATOR BIOSCIENCE AND IMMUNO-ONCOLOGY Alli IOTN THE IMMUNO-ONCOLOGY TRANSLATIONAL NETWORK Advancing Research Progress to Improve Immunotherapy and Immunoprevention Blue Ribbon Panel’s Recommendation: Create A Translational Science Netw What is clinical oncology?. “Intellectually . stimulating and rewarding. ”. “One of the most interesting and rapidly advancing areas of medicine”. “There’s no risk of getting . bored”. “People who have a real mission for what they do”. Dr Ollie Minton . National Picture. 29% . NHS spending is on patients in the . last year of their life. 1:3 . of the adult inpatient population is in the last year of their life. 1:10. is in their last admission.